Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Habitual consumption of significant amounts ( . 10% energy) of dietary fructose contributes to TG elevations, particularly in people with HTG.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The impact of fructose/sucrose intake on HDL-C does not seem different from that of other refined carbohydrates.158,159”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sucrose, a disaccharidecontaining glucose and fructose, represents an important source of fructose in the diet. 158,175”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fructose has emerged as a potent activator of carbohydrate response element-binding protein (ChREBP), which is particularly relevant in the context of MASLD, given the global rise in fructose consumption that parallels the increasing prevalence of MASLD [78- 82].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“dietary fructose contributes to TG elevations; these effects are dose dependent and become clinically relevant when the intake is .10%energy daily-with a habitual fructose consumption between 15 and 20% of the energy intake, plasma TG increases as much as 30 -40%.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [76]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
A new predictive equation for resting energy expenditure in healthy individuals
Mifflin, M., St Jeor, S., Hill, L., Scott, B., Daugherty, S., & Koh, Y. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.2.241 · Cited by 2,544 · cited 1×
“calculated by the Mifflin equation (67), with an adjustment of 1.”
MethodNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Diacylglycerol is a known activator of novel PKC (51), and increases of both diacylglycerol and novel PKC activity are associated with lipid-induced insulin resistance (52, 53).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundConway, J. M., Ingwersen, L. A., Vinyard, B. T., & Moshfegh, A. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1171 · Cited by 820
Research works printed but not linked: 1
- Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42 :A39.
Cited by
Items 301–400 of 1,008
Patel, C., Douard, V., Yu, S., Tharabenjasin, P., Gao, N., & Ferraris, R. P. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00128.2015 · Cited by 93
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Paglialunga, S., & Dehn, C. A. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0321-5 · Cited by 111
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 105
Carpentier, A. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2020 · Cited by 108
Mager, D. R., Rivera‐Íñiguez, I., Gilmour, S. M., & Yap, J. Y. K. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113501201 · Cited by 102
Raben, A., Møller, B., Flint, A., Vasilaras, T., Christina Møller, A., Juul Holst, J., & Astrup, A. (2011) · Food & Nutrition Research · doi:10.3402/fnr.v55i0.5961 · Cited by 84
Misconceptions about fructose-containing sugars and their role in the obesity epidemic
van Buul, V. J., Tappy, L., & Brouns, F. J. P. H. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000067 · Cited by 89
Adipose Tissue Macrophage Polarization in Healthy and Unhealthy Obesity
Ruggiero, A. D., Key, C.-C. C., & Kavanagh, K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.625331 · Cited by 98
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
Nseir, W., Shalata, A., Marmor, A. T., & Assy, N. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1767-y · Cited by 94
The obesogenic effect of high fructose exposure during early development
Goran, M. I., Dumke, K., Bouret, S. G., Kayser, B., Walker, R. W., & Blumberg, B. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.108 · Cited by 89
Brain functional magnetic resonance imaging response to glucose and fructose infusions in humans
Purnell, J. Q., Klopfenstein, B. A., Stevens, A. A., Havel, P. J., Adams, S. H., Dunn, T. N., Krisky, C., & Rooney, W. D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01340.x · Cited by 85
Self-citationSvihus, B., & Hervik, A. K. (2016) · Starch - Stärke · doi:10.1002/star.201500295 · Cited by 104
Insulin resistance and bariatric surgery
Rao, R. S., Yanagisawa, R., & Kini, S. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00955.x · Cited by 89
Attention-Deficit/Hyperactivity Disorder: Is it time to Reappraise the Role of Sugar Consumption?
Johnson, R. J., Gold, M. S., Johnson, D. R., Ishimoto, T., Lanaspa, M. A., Zahniser, N. R., & Avena, N. M. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2458 · Cited by 105
Zhang, Y., Wang, L., Zhang, J., Li, Y., He, Q., Li, H., Guo, X., Guo, J., & Zhang, H. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0519-5 · Cited by 96
Fructose: Pure, White, and Deadly? Fructose, by Any other Name, is a Health Hazard
Bray, G. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400432 · Cited by 91
Stanhope, K. L., Goran, M. I., Bosy‐Westphal, A., King, J. C., Schmidt, L. A., Schwarz, J. ‐., Stice, E., Sylvetsky, A. C., Turnbaugh, P. J., Bray, G. A., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12699 · Cited by 87
Self-citationHydes, T., Ravi, S., Loomba, R. S., & Gray, M. E. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0067 · Cited by 94
Sonestedt, E., Øverby, N. C., Laaksonen, D. E., & Birgisdóttir, B. E. (2012) · Food & Nutrition Research · doi:10.3402/fnr.v56i0.19104 · Cited by 99
Zhang, Y. H., An, T., Zhang, R. C., Zhou, Q., Huang, Y., & Zhang, J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175323 · Cited by 95
Sugars, obesity, and cardiovascular disease: results from recent randomized control trials
Rippe, J. M., & Angelopoulos, T. J. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1257-2 · Cited by 88
“Other investigators have utilized a similar model in overweight or obese subjects and demonstrated that fructose sweetened beverages, when compared to glucose sweetened beverages, when consumed at 25 % of energy, were resulted in increased postprandial triglyceride concentrations in overweight/obese subjects compared…”
BackgroundWagner, J. G., Allen, K., Yang, H.-Y., Nan, B., Morishita, M., Mukherjee, B., Dvonch, J. T., Spino, C., Fink, G. D., Rajagopalan, S., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307085 · Cited by 88
Lawrence, G. D. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab013 · Cited by 93
Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity
Hervik, A. K., & Svihus, B. (2015) · Journal of Nutrition and Metabolism · doi:10.1155/2015/823081 · Cited by 98
Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)
Fuchs, M. A., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099816 · Cited by 84
Carbohydrate intake and nonalcoholic fatty liver disease
Neuschwander-Tetri, B. A. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328361c4d1 · Cited by 89
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
Dongiovanni, P., & Valenti, L. V. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071534 · Cited by 93
Mollard, R. C., Sénéchal, M., MacIntosh, A., Hay, J. L., Wicklow, B. A., Wittmeier, K. D. M., Sellers, E. A. C., Dean, H., Ryner, L. N., Berard, L., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079277 · Cited by 94
DiStefano, J. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03390-0 · Cited by 93
Liu, C.-Y., Chou, Y., Chao, J. C.-J., Hsu, C., Cha, T., & Tsao, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134224 · Cited by 87
Obesity and energy balance: is the tail wagging the dog?
Wells, J. C. K., & Siervo, M. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.132 · Cited by 102
Bravo, S., Lowndes, J., Sinnett, S., Yu, Z., & Rippe, J. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0322 · Cited by 86
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Keirns, B. H., Sciarrillo, C. M., Koemel, N. A., & Emerson, S. R. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.73 · Cited by 86
Cohen, C. C., Li, K. W., Alazraki, A. L., Beysen, C., Carrier, C., Cleeton, R. L., Dandan, M., Figueroa, J., Knight‐Scott, J., Knott, C. J., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150996 · Cited by 92
Self-citationThe Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
Erion, D. M., Popov, V., Hsiao, J. J., Vatner, D., Mitchell, K., Yonemitsu, S., Nagai, Y., Kahn, M., Gillum, M. P., Dong, J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1725 · Cited by 84
A Diet Rich in Vegetables and Fruit and Incident CKD: A Community-Based Prospective Cohort Study
Jhee, J. H., Kee, Y. K., Park, J. T., Chang, T. I., Kang, E. W., Yoo, T., Kang, S., & Han, S. H. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.02.023 · Cited by 94
Insights into the Hexose Liver Metabolism—Glucose versus Fructose
Geidl-Flueck, B., & Gerber, P. (2017) · Nutrients · doi:10.3390/nu9091026 · Cited by 85
“Fructose has generally been recognized as sugar that decreases insulin sensitivity and promotes dyslipidemia [131,132].”
BackgroundLuo, Y., Burrington, C. M., Graff, E. C., Zhang, J., Judd, R. L., Suksaranjit, P., Kaewpoowat, Q., Davenport, S. K., O’Neill, A. M., & Greene, M. W. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00319.2015 · Cited by 89
Sweet but Bitter: Focus on Fructose Impact on Brain Function in Rodent Models
Spagnuolo, M. S., Iossa, S., & Cigliano, L. (2020) · Nutrients · doi:10.3390/nu13010001 · Cited by 92
Kazierad, D. J., Chidsey, K., Somayaji, V. R., Bergman, A. J., Birnbaum, M. J., & Calle, R. A. (2021) · Med · doi:10.1016/j.medj.2021.04.007 · Cited by 83
Gao, H., Guan, T., Li, C., Zuo, G., Yamahara, J., Wang, J., & Li, Y. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/570948 · Cited by 82
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
Sugar sweetened beverages and cardiometabolic health
Malik, V. S. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000439 · Cited by 84
Futatsugi, K., Smith, A. C. T., Tu, M., Raymer, B. K., Ahn, K., Coffey, S. B., Dowling, M., Fernando, D. P., Gutierrez, J. A., Huard, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00944 · Cited by 90
Fructose drives de novo lipogenesis affecting metabolic health
Geidl, B., & Gerber, P. A. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0270 · Cited by 103
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Keim, N. L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1050 · Cited by 88
Self-citationChiu, Y. H., Afeiche, M. C., Gaskins, A. J., Williams, P. L., Mendiola, J., Jørgensen, N., Swan, S. H., & Chavarro, J. E. (2014) · Human Reproduction · doi:10.1093/humrep/deu102 · Cited by 83
Stanhope, K. L., Griffen, S. C., Bremer, A. A., Vink, R., Schaefer, E. J., Nakajima, K., Schwarz, J., Beysen, C., Berglund, L., Keim, N. L., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002246 · Cited by 92
Self-citationJameel, F., Phang, M., Wood, L. G., & Garg, M. L. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-195 · Cited by 87
Shin, S., Kim, S.-A., Ha, J., & Lim, K. (2018) · Nutrients · doi:10.3390/nu10101467 · Cited by 78
A Review on the Protective Effects of Honey against Metabolic Syndrome
Ramli, N. Z., Chin, K., Zarkasi, K. A., & Ahmad, F. (2018) · Nutrients · doi:10.3390/nu10081009 · Cited by 91
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
Federico, A., Rosato, V., Masarone, M., Torre, P., Dallio, M., Romeo, M., & Persico, M. (2021) · Nutrients · doi:10.3390/nu13041314 · Cited by 91
Ohashi, K., Munetsuna, E., Yamada, H., Ando, Y., Yamazaki, M., Taromaru, N., Nagura, A., Ishikawa, H., Suzuki, K. A. O., Teradaira, R., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.134 · Cited by 89
Fructose-Rich Beverage Intake and Central Adiposity, Uric Acid, and Pediatric Insulin Resistance
Lin, W., Chan, T., Huang, H., Lee, C., Tsai, S., Wu, P., Yang, Y.-C., Wang, T., & Lee, C. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.12.061 · Cited by 90
The Metabolic Ghetto: An Evolutionary Perspective on Nutrition, Power Relations and Chronic Disease
Wells, J. C. K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9780511972959 · Cited by 76
High Fructose Intake and Adipogenesis
Hernández-Díazcouder, A., Romero‐Nava, R., Carbó, R., Sánchez‐Lozada, L. G., & Sánchez‐Muñoz, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112787 · Cited by 90
Dolan, L. C., Potter, S. M., & Burdock, G. A. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903461426 · Cited by 80
Regulation of chylomicron production in humans
Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 91
Dietary Sugar and Artificial Sweetener Intake and Chronic Kidney Disease: A Review
Karalius, V. P., & Shoham, D. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.12.005 · Cited by 92
The role and requirements of digestible dietary carbohydrates in infants and toddlers
Stephen, A. M., Alles, M., de Graaf, C., Fleith, M., Hadjilucas, E., Isaacs, E., Maffeis, C., Zeinstra, G. G., Matthys, C., & Gil, Á. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.27 · Cited by 100
Wang, H., Sun, R., Zeng, X., Zhou, X., Li, S., Jo, E., Molero, J. C., & Ye, J. (2014) · Endocrinology · doi:10.1210/en.2014-1454 · Cited by 81
Sugar sweetened beverage consumption by Australian children: Implications for public health strategy
Hafekost, K., Mitrou, F., Lawrence, D. M., & Zubrick, S. R. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-950 · Cited by 85
Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
Russo, E., Leoncini, G., Esposito, P. B., Garibotto, G., Pontremoli, R., & Viazzi, F. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124479 · Cited by 88
Making progress on the global crisis of obesity and weight management
Lean, M. E. J., Astrup, A. V., & Roberts, S. B. (2018) · BMJ · doi:10.1136/bmj.k2538 · Cited by 83
Tissue-Specific Fructose Metabolism in Obesity and Diabetes
Helsley, R. N., Moreau, F., Gupta, M. K., Radulescu, A., DeBosch, B. J., & Softic, S. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01342-8 · Cited by 86
Lubawy, M., & Formanowicz, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043596 · Cited by 87
Sugar‐Sweetened and Diet Beverages in Relation to Visceral Adipose Tissue
Odegaard, A. O., Choh, A. C., Czerwinski, S. A., Towne, B., & Demerath, E. W. (2012) · Obesity · doi:10.1038/oby.2011.277 · Cited by 72
Hepatic fatty acid partitioning
Hodson, L., & Frayn, K. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283462e16 · Cited by 75
Jin, R., Le, N., Liu, S., Epperson, M., Ziegler, T. R., Welsh, J. A., Jones, D. P., McClain, C. J., & Vos, M. B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1370 · Cited by 77
Mazidi, M., Kengne, A. P., Mikhailidis, D. P., Cicero, A. F., & Banach, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1325967 · Cited by 73
Farhangi, M. A., Tofigh, A. M., Jahangiri, L., Nikniaz, Z., & Nikniaz, L. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12914 · Cited by 87
Patel, C., Sugimoto, K., Douard, V., Shah, A., Inui, H., Yamanouchi, T., & Ferraris, R. P. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00188.2015 · Cited by 71
Pan, Y., & Kong, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.020 · Cited by 78
Sugar-sweetened beverages, vascular risk factors and events: a systematic literature review
Keller, A., Heitmann, B. L., & Olsen, N. (2015) · Public Health Nutrition · doi:10.1017/s1368980014002122 · Cited by 75
Obesity and the liver: nonalcoholic fatty liver disease
Koppe, S. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.008 · Cited by 81
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data
Yki-Järvinen, H. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833f4b34 · Cited by 71
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
Shepherd, E. L., Saborano, R., Northall, E., Matsuda, K., Ogino, H., Yashiro, H., Pickens, J., Feaver, R. E., Cole, B. K., Hoang, S. A., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2020.100217 · Cited by 70
Quantitative flux analysis in mammals
Bartman, C. R., TeSlaa, T., & Rabinowitz, J. D. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00419-2 · Cited by 70
Kinote, A., Faria, J. A., Roman, E. A., Solon, C., Razolli, D. S., Ignacio-Souza, L. M., Sollon, C. S., Nascimento, L. F., de Araújo, T. M., Barbosa, A. P. L., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1341 · Cited by 68
Feinman, R. D., & Fine, E. J. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-45 · Cited by 89
Regulation of Adipose Differentiation by Fructose and GluT5
Du, L., & Heaney, A. P. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1122 · Cited by 77
Dual probiotic strains suppress high fructose-induced metabolic syndrome
Park, D.-Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.274 · Cited by 71
Sakar, Y., Nazaret, C., Lettéron, P., Omar, A. A., Avenati, M., Viollet, B., Ducroc, R. A., & Bado, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007935 · Cited by 79
Pektaş, M. B., Koca, H. B., Sadı, G., & Akar, F. (2016) · BioMed Research International · doi:10.1155/2016/8014252 · Cited by 73
Nakajima, K., Nagamine, T., Fujita, M., Ai, M., Tanaka, A., & Schaefer, E. J. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800263-6.00003-3 · Cited by 89
Self-citationEffects of Diet on High-Density Lipoprotein Cholesterol
Siri‐Tarino, P. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0207-y · Cited by 76
Chai, S. C., Davis, K., Wright, R. S., Kuczmarski, M. F., & Zhang, Z. (2018) · Food & Function · doi:10.1039/c8fo00468d · Cited by 75
Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia
Desmarchelier, C., Borel, P., Lairon, D., Maraninchi, M., & Valéro, R. (2019) · Nutrients · doi:10.3390/nu11061299 · Cited by 75
The inflammatory profile and liver damage of a sucrose-rich diet in mice
Oliveira, L. S. C., Santos, D. A., Barbosa‐da‐Silva, S., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.006 · Cited by 73
Mastrocola, R., Ferrocino, I., Liberto, E., Chiazza, F., Cento, A. S., Collotta, D., Querio, G., Nigro, D., Bitonto, V., Cutrin, J. C., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.003 · Cited by 68
El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i10.2931 · Cited by 69
Sugar-sweetened beverages and cardio-metabolic disease risks
Richelsen, B. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328361c53e · Cited by 65
Fructose, pregnancy and later life impacts
Regnault, T. R. H., Gentili, S., Sarr, O., Toop, C. R., & Sloboda, D. M. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12162 · Cited by 75
Dekker, M. J., Baker, C., Naples, M., Samsoondar, J. P., Zhang, R., Qiu, W., Sacco, J., & Adeli, K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.041 · Cited by 73
Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20
Liu, G., Zhou, L., Zhang, H., Chen, R., Zhang, Y., Li, L., Lu, J.-Y., Jiang, H., Liu, D., Qi, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14824 · Cited by 73
Self-citationEarly nocturnal meal skipping alters the peripheral clock and increases lipogenesis in mice
Yoshida, C., Shikata, N., Seki, S., Koyama, N., & Noguchi, Y. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-78 · Cited by 65
Triose Kinase Controls the Lipogenic Potential of Fructose and Dietary Tolerance
Liu, L., Li, T., Liao, Y., Wang, Y., Gao, Y., Hu, H., Huang, H., Wu, F., Chen, Y., Xu, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.018 · Cited by 72
Fructose and Non-Alcoholic Steatohepatitis
Roeb, E., & Weiskirchen, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634344 · Cited by 62
Tillman, E. J., Morgan, D. A., Rahmouni, K., & Swoap, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107206 · Cited by 70
Hernández-Cordero, S., Barquera, S., Rodríguez-Ramírez, S., Villanueva-Borbolla, M. A., González de Cossio, T., Dommarco, J. R., & Popkin, B. (2014) · The Journal of Nutrition · doi:10.3945/jn.114.193490 · Cited by 63
Metadata
- Authors
- Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
- Affiliations
- University of California, Davis (US)
- University of California, San Francisco (US)
- United States Department of Agriculture (US)
- Touro University California (US)
- UCSF Benioff Children's Hospital (US)
- Tufts University (US)
- KineMed (United States) (US)
- VA Northern California Health Care System (US)
- Corresponding author
- Havel, Peter J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-05-01
- Volume
- 119
- Issue
- 5
- Pages
- 1322-1334
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2673878
- OpenAlex
- W2146966453
- Cited by
- 1,765
- References
- 86
- Citations by year
- 2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
- FWCI
- 74.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association (UL1 RR024146)
- U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- American College of Radiology Imaging Network
- School of Veterinary Medicine, University of California, Davis
- KineMed
- Novo Nordisk
- Otsuka Pharmaceutical
- National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
- University of California, Davis (95616, RR024146, UL1 RR024146)
- Agricultural Research Service (5306‐51530‐016‐00D)
- National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
- National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
- National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
- MeSH terms
- Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.